BIOTE CORP -A (BTMD) Stock Price & Overview
NASDAQ:BTMD • US0906831039
Current stock price
The current stock price of BTMD is 1.53 USD. Today BTMD is up by 6.25%. In the past month the price decreased by -27.14%. In the past year, price decreased by -60.36%.
BTMD Key Statistics
- Market Cap
- 60.512M
- P/E
- 1.84
- Fwd P/E
- 6.00
- EPS (TTM)
- 0.83
- Dividend Yield
- N/A
BTMD Stock Performance
BTMD Stock Chart
BTMD Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to BTMD. When comparing the yearly performance of all stocks, BTMD is a bad performer in the overall market: 95.14% of all stocks are doing better.
BTMD Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to BTMD. While BTMD has a great profitability rating, there are some minor concerns on its financial health.
BTMD Earnings
On March 11, 2026 BTMD reported an EPS of 0.06 and a revenue of 46.41M. The company beat EPS expectations (17.65% surprise) and missed revenue expectations (-1.5% surprise).
BTMD Forecast & Estimates
11 analysts have analysed BTMD and the average price target is 4.94 USD. This implies a price increase of 222.89% is expected in the next year compared to the current price of 1.53.
For the next year, analysts expect an EPS growth of -69.28% and a revenue growth 0.32% for BTMD
BTMD Groups
Sector & Classification
BTMD Financial Highlights
Over the last trailing twelve months BTMD reported a non-GAAP Earnings per Share(EPS) of 0.83. The EPS increased by 277.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 14.07% | ||
| ROA | 25.13% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
BTMD Ownership
BTMD Latest News, Press Relases and Analysis
BTMD Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 25.94 | 865.533B | ||
| JNJ | JOHNSON & JOHNSON | 20.21 | 572.592B | ||
| MRK | MERCK & CO. INC. | 22.06 | 282.347B | ||
| PFE | PFIZER INC | 9.03 | 155.861B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.08 | 118.339B | ||
| ZTS | ZOETIS INC | 16.34 | 48.963B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.78 | 26.264B | ||
| VTRS | VIATRIS INC | 5.26 | 15.544B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.8 | 12.489B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.127B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.974B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 5.21B | ||
| LGND | LIGAND PHARMACEUTICALS | 24.12 | 4.197B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About BTMD
Company Profile
biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. The company is headquartered in Irving, Texas and currently employs 223 full-time employees. The company went IPO on 2021-03-02. The firm provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. The company also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Company Info
IPO: 2021-03-02
BIOTE CORP -A
1875 W. Walnut Hill Ln #100, Floor 5
Irving TEXAS US
Employees: 223
Phone: 19724869346
BIOTE CORP -A / BTMD FAQ
Can you describe the business of BIOTE CORP -A?
biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. The company is headquartered in Irving, Texas and currently employs 223 full-time employees. The company went IPO on 2021-03-02. The firm provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. The company also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Can you provide the latest stock price for BIOTE CORP -A?
The current stock price of BTMD is 1.53 USD. The price increased by 6.25% in the last trading session.
What is the dividend status of BIOTE CORP -A?
BTMD does not pay a dividend.
What is the ChartMill technical and fundamental rating of BTMD stock?
BTMD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What is the analyst forecast for BTMD stock?
11 analysts have analysed BTMD and the average price target is 4.94 USD. This implies a price increase of 222.89% is expected in the next year compared to the current price of 1.53.
What is the employee count for BTMD stock?
BIOTE CORP -A (BTMD) currently has 223 employees.
What is the next earnings date for BTMD stock?
BIOTE CORP -A (BTMD) will report earnings on 2026-05-05.